Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[MSA update].

Shoji Tsuji1

  • 1Department of Neurology, Graduate School of Medicine, University of Tokyo.

Rinsho Shinkeigaku = Clinical Neurology
|February 2, 2006
PubMed
Summary
This summary is machine-generated.

Multiple system atrophy (MSA) is a rare neurodegenerative disease. Research is identifying genetic links in both familial and sporadic cases to understand its cause.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early detection of cognitive decline in Alzheimer's disease using eye tracking.

Frontiers in aging neuroscience·2023
Same author

Genetics of familial adult myoclonus epilepsy: From linkage studies to noncoding repeat expansions.

Epilepsia·2023
Same author

The Myocardial Accumulation of Aggregated Desmin Protein in a Case of Desminopathy with a de novo DES p.R406W Mutation.

Internal medicine (Tokyo, Japan)·2023
Same author

[New MDS Criteria for the Diagnosis of Multiple System Atrophy: Overview and Genetic Viewpoint].

Brain and nerve = Shinkei kenkyu no shinpo·2023
Same author

History of familial adult myoclonus epilepsy/benign adult familial myoclonic epilepsy around the world.

Epilepsia·2023
Same author

Comparison of the characteristics and factors influencing hospital visits among children with nocturnal enuresis in Japan: The Hirakata-Urayasu population-based cohort study.

International journal of urology : official journal of the Japanese Urological Association·2023
Same journal

[Utility of acute-phase cerebral blood flow single photon emission computed tomography (SPECT) for evaluating the pathophysiology of Bickerstaff brainstem encephalitis with decorticate posturing].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Successful treatment with rituximab in unilateral relapsing primary CNS vasculitis: a ‍case report].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Clinical management of headache comorbid with functional neurological disorder].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Transient myoclonic state with asterixis related to COVID-19].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Let's present at a regional meeting].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Editor's Note].

Rinsho shinkeigaku = Clinical neurology·2026
See all related articles

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Context:

  • Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder with overlapping clinical features of parkinsonism, cerebellar ataxia, and autonomic failure.
  • Historically distinct clinical syndromes like olivopontocerebellar atrophy (OPCA), striatonigral degeneration (SND), and Shy-Drager syndrome are now recognized under the umbrella of MSA.
  • The identification of glial cytoplasmic inclusions (GCIs) as the pathognomonic hallmark has unified these presentations into a single clinicopathological entity.

Purpose:

  • To establish the clinicopathological entity of Multiple System Atrophy (MSA) based on pathognomonic findings.
  • To investigate the epidemiological prevalence of MSA, particularly in Japan, where it is the most common sporadic ataxia.
  • To explore the genetic underpinnings of MSA by analyzing familial and sporadic cases, aiming to identify genes involved in its pathogenesis.

Related Experiment Videos

Summary:

  • Recent research has unified previously distinct clinical syndromes under the clinicopathological entity of Multiple System Atrophy (MSA), characterized by glial cytoplasmic inclusions (GCIs).
  • Epidemiological data indicates MSA is the most common sporadic ataxia in Japan, with olivopontocerebellar atrophy (OPCA) being the most frequent clinical subtype.
  • While traditionally considered sporadic, familial occurrences of MSA have been identified, prompting integrated genetic analyses (linkage and association studies) to uncover causative genes.

Impact:

  • Clarifies the diagnostic criteria for Multiple System Atrophy (MSA) by establishing a unified clinicopathological definition.
  • Highlights the significant epidemiological burden of MSA, particularly as a leading cause of sporadic ataxia in specific populations.
  • Advances the understanding of MSA pathogenesis by paving the way for genetic discoveries through integrated familial and sporadic case analyses.